Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 218

Results For "Development"

2919 News Found

NIBIOHN identifies tissue-specific exosome marker candidates from blood
Biotech | March 22, 2022

NIBIOHN identifies tissue-specific exosome marker candidates from blood

Blood contains a mixture of exosomes secreted from nearly all tissues and cells, and exosomes from other tissues can mask changes caused by disease, making it difficult to detect the presence of biomarkers that reflect disease


Intravacc publishes a GMP process for a semi-synthetic Shigella glycoconjugate vaccine
Biotech | March 22, 2022

Intravacc publishes a GMP process for a semi-synthetic Shigella glycoconjugate vaccine

Data published in the prestigious journal ACS Central Science of the American Chemical Society


Mandaviya launches BRICS vaccine R&D centre
Policy | March 22, 2022

Mandaviya launches BRICS vaccine R&D centre

The Centre will be instrumental in streamlining vaccination resources and facilitate equitable access to safe and efficacious COVID-19 vaccines


Glenmark receives ANDA approval for Lacosamide tablets
Drug Approval | March 21, 2022

Glenmark receives ANDA approval for Lacosamide tablets

The company plans to launch the product immediately


Biological Dynamics study demonstrates detection of early-stage cancers
Biotech | March 21, 2022

Biological Dynamics study demonstrates detection of early-stage cancers

In a Nature Communications Medicine publication, the Verita proprietary platform detected 96 per cent of stage 1 pancreatic cancers and three-quarters of stage 1 ovarian cancers using isolated exosomes and AI-enabled protein marker analysis


Hetero gets CDSCO approval to manufacture and sell Sputnik Light in India
News | March 21, 2022

Hetero gets CDSCO approval to manufacture and sell Sputnik Light in India

Sputnik Light is the first component of Sputnik V


RNAGene and PharmAbcine to develop novel mRNA therapeutics
Biotech | March 21, 2022

RNAGene and PharmAbcine to develop novel mRNA therapeutics

mRNA-based therapies involve the administration of mRNA in patients so that patients' own cells can produce the encoded therapeutic antibody


Lonza signs manufacturing agreement with Oasmia Pharmaceutical
News | March 21, 2022

Lonza signs manufacturing agreement with Oasmia Pharmaceutical

Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply


USFDA approves Opdualag to treat metastatic melanoma
Drug Approval | March 19, 2022

USFDA approves Opdualag to treat metastatic melanoma

Opdualag is a first-in-class, fixed-dose dual immunotherapy combination treatment of the PD-1 inhibitor nivolumab and novel LAG-3-blocking antibody relatlimab


USFDA approves Marinus’ treatment for genetic disorder
Drug Approval | March 19, 2022

USFDA approves Marinus’ treatment for genetic disorder

First and only FDA-approved treatment for seizures associated with CDKL5 deficiency disorder (CDD) in patients two years of age and older